J. Irvin

发表

Burkitt Lymphoma Genome Sequencing Project (BLGSP): Introduction

L. Staudt, T. Greiner, D. Gerhard, 2016 .

Enalapril: A Review of Human Pharmacology

V. Cirillo, H. Gomez, J. Irvin, 2012, Drugs.

109. Efficacy and safety of oral MK-954 (DuP 753), an angiotensin receptor antagonist, in essential hypertension

T. Bradstreet, E. Nelson, F. Mcmahon, 1991 .

Neurohumoral Control of Blood Vessels

H. Weiss, P. M. Gootman, R. Clauss, 1976 .

Tolerability of Long Term Therapy with Enalapril Maleate in Patients Resistant to Other Therapies and Intolerant to Captopril

J. Rush, E. Rucinska, R. Smith, 1989, Medical toxicology and adverse drug experience.

Effects of enalapril, a new converting enzyme inhibitor, in hypertension

B. Swanson, P. Vlasses, R. K. Ferguson, 1982, Clinical pharmacology and therapeutics.

Synergistic antihypertensive effect of MK-421 and hydrochlorothiazide

R. Davies, B. Swanson, P. Vlasses, 1982 .

The effect of renal function on enalapril kinetics

D. Lowenthal, E. Ulm, K. Harris, 1985, Clinical pharmacology and therapeutics.

BIOAVAILABILITY OF ENALAPRIL MALEATE

H. Rotmensch, P. Vlasses, J. Irvin, 1984 .

A Comparative Pilot Study of Enalapril, A New Converting Enzyme Inhibitor, and Hydrochlorothiazide in Essential Hypertension

B. Swanson, P. Vlasses, R. K. Ferguson, 1982, Journal of clinical pharmacology.

Safety profiles of the angiotensin converting enzyme inhibitors captopril and enalapril.

J. Irvin, J. Viau, 1986, The American journal of medicine.

Enantiomers of Indacrinone

P. Vlasses, R. K. Ferguson, J. Tobert, 1985 .

Antihypertensive efficacy of once daily MK-521, a new nonsulfhydryl angiotensin-converting enzyme inhibitor.

H. Rotmensch, B. Swanson, P. Vlasses, 1984, The American journal of cardiology.

Influence of food on the bioavailability of enalapril.

B. Swanson, P. Vlasses, R. K. Ferguson, 1984, Journal of pharmaceutical sciences.

A Consumer Use Study of Over-The-Counter lovastatin (CUSTOM).

J. Reynolds, J. Melin, T. Vassil, 2004, The American journal of cardiology.

Antihypertensive Effect of Enalapril in Essential Hypertension: Role of Prostacyclin

S. Oparil, R. Horton, J. Irvin, 1987, The American journal of the medical sciences.

Pharmacology of enantiomers and (–) p‐OH metabolite of indacrinone

R. Davies, P. Vlasses, R. K. Ferguson, 1981, Clinical pharmacology and therapeutics.

Comparative Antihypertensive Effects of Enalapril Maleate and Hydrochlorothiazide, Alone and in Combination

H. Rotmensch, B. Swanson, P. Vlasses, 1983, Journal of clinical pharmacology.

Role of Adrenergic Nerves in Blood-Induced Cerebral Vasospasm

F. Simeone, J. Alderman, J. Irvin, 1979, Stroke.

Initial evaluation of the non-sulfhydryl-containing converting enzyme inhibitor MK-521 in hypertensive humans.

H. Rotmensch, B. Swanson, P. Vlasses, 1984, Federation proceedings.

Nonpeptide angiotensin II receptor antagonists: the next generation in antihypertensive therapy.

K Prendergast, W. Greenlee, P. Timmermans, 1996, Journal of medicinal chemistry.

Genome-wide discovery of somatic coding and noncoding mutations in pediatric endemic and sporadic Burkitt lymphoma.

Steven J. M. Jones, Ryan D. Morin, Nicholas B. Griner, 2019, Blood.

Genetic subgroups inform on pathobiology in adult and pediatric Burkitt lymphoma

Ryan D. Morin, Nicholas B. Griner, L. Staudt, 2021, medRxiv.

The influence of the adrenal glands upon acute spinal cord injury.

J. Alderman, J. Osterholm, J. Irvin, 1980, Life sciences.

Chapter 29. Anti-norepinephrine therapy against traumatic hemorrhagic necrosis of the spinal cord: preliminary report.

B. Calesnick, J. Osterholm, G. Mathews, 1973, Clinical neurosurgery.

Comparison of oral indacrinone with furosemide

R. Davies, R. K. Ferguson, J. Irvin, 1980, Clinical pharmacology and therapeutics.

High-risk patients treated with enalapril maleate: safety considerations.

E. Rucinska, J. Irvin, R. Small, 1989, International journal of cardiology.

Enalapril worldwide experience.

R. Davies, J. Walker, F. Moncloa, 1984, The American journal of medicine.

An overview of the clinical pharmacology of enalapril.

R. Davies, H. Gomez, J. Walker, 1984, British journal of clinical pharmacology.

Anoverview oftheclinical pharmacology ofenalapril

H. Gomez, J. Walker, J. Irvin, 1984 .

Extended‐release felodipine in patients with mild to moderate hypertension

D. A. Shapiro, E. Faison, E. Nelson, 1994, Clinical pharmacology and therapeutics.

Enalapril and Hydrochlorothiazide as Antihypertensive Agents in the Elderly

J. Lewis, D. A. Shapiro, C. Liss, 1987, Journal of cardiovascular pharmacology.

KEY GENETIC AND MOLECULAR ABERRATIONS IDENTIFIED IN BOTH ADULT AND EBV‐POSITIVE BURKITT LYMPHOMA PATIENTS

L. Staudt, W. Wilson, D. Gerhard, 2021, Hematological Oncology.

Evidence for route dependent biotransformation of cyclobenzaprine hydrochloride.

M. Constanzer, R. K. Ferguson, J. Demetriades, 1982, Biopharmaceutics & drug disposition.

Indacrinone: Natriuretic and Uricosuric Effects of Various Ratios of Its Enantiomers in Healthy Men

H. Rotmensch, P. Vlasses, R. K. Ferguson, 1984, Pharmacotherapy.